Search research articles
Contact Us
Filters
Showing results (71-80 of 86) with videos related to
Page
of 9
Sort By:
Journal of Child and Adolescent Psychopharmacology
|
February 2, 2023
Efficacy of Amphetamine Extended-Release Oral Suspension in Children with Attention-Deficit/Hyperactivity Disorder: Effect Size Across the Day
Stephen V Faraone, Ann C Childress, Roberto Gomeni, et al.
Neuropsychiatric Disease and Treatment
|
December 24, 2013
Analysis of individual items on the attention-deficit/hyperactivity disorder symptom rating scale in children and adults: the effects of age and sex in pivotal trials of lisdexamfetamine dimesylate
Richard H Weisler, Lenard A Adler, Scott H Kollins, et al.
Journal of the American Academy of Child and Adolescent Psychiatry
|
March 23, 2011
Efficacy and safety of lisdexamfetamine dimesylate in adolescents with attention-deficit/hyperactivity disorder
Robert L Findling, Ann C Childress, Andrew J Cutler, et al.
Journal of Child and Adolescent Psychopharmacology
|
March 4, 2020
Randomized, Double-Blind, Placebo-Controlled, Flexible-Dose Titration Study of Methylphenidate Hydrochloride Extended-Release Capsules (Aptensio XR) in Preschool Children with Attention-Deficit/Hyperactivity Disorder
Ann C Childress, Scott H Kollins, Henry C Foehl, et al.
Neuropsychiatric Disease and Treatment
|
June 11, 2021
The Effect of Viloxazine Extended-Release Capsules on Functional Impairments Associated with Attention-Deficit/Hyperactivity Disorder (ADHD) in Children and Adolescents in Four Phase 3 Placebo-Controlled Trials
Azmi Nasser, Joseph T Hull, Tesfaye Liranso, et al.
Journal of Child and Adolescent Psychopharmacology
|
December 7, 2017
Efficacy and Safety of Amphetamine Extended-Release Oral Suspension in Children with Attention-Deficit/Hyperactivity Disorder
Ann C Childress, Sharon B Wigal, Matthew N Brams, et al.
The Journal of Clinical Psychiatry
|
July 20, 2022
Randomized, Double-Blind, Placebo-Controlled, Fixed-Dose Study to Evaluate the Efficacy and Safety of Amphetamine Extended-Release Tablets in Adults With Attention-Deficit/Hyperactivity Disorder
Andrew J Cutler, Ann C Childress, Antonio Pardo, et al.
Npj Mental Health Research
|
August 22, 2025
Real-world effectiveness of a widely available digital health program in adults reporting a lifetime diagnosis of ADHD
Allen M Osman, Kevin P Madore, Paul I Jaffe, et al.
Journal of Child and Adolescent Psychopharmacology
|
April 30, 2024
From Consensus Statement to Pills to Pixels: New Innovations in Attention-Deficit/Hyperactivity Disorder Care
Raman Baweja, Stephen V Faraone, Ann C Childress, et al.
The Journal of Clinical Psychiatry
|
June 24, 2021
Symptomatic and Functional Response and Remission From the Open-Label Treatment-Optimization Phase of a Study With DR/ER-MPH in Children With ADHD
Ann C Childress, Andrew J Cutler, Michelle D Po, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 86) with videos related to
Sort By:
Page
of 9
Journal of Child and Adolescent Psychopharmacology
|
February 2, 2023
Efficacy of Amphetamine Extended-Release Oral Suspension in Children with Attention-Deficit/Hyperactivity Disorder: Effect Size Across the Day
Stephen V Faraone, Ann C Childress, Roberto Gomeni, et al.
Neuropsychiatric Disease and Treatment
|
December 24, 2013
Analysis of individual items on the attention-deficit/hyperactivity disorder symptom rating scale in children and adults: the effects of age and sex in pivotal trials of lisdexamfetamine dimesylate
Richard H Weisler, Lenard A Adler, Scott H Kollins, et al.
Journal of the American Academy of Child and Adolescent Psychiatry
|
March 23, 2011
Efficacy and safety of lisdexamfetamine dimesylate in adolescents with attention-deficit/hyperactivity disorder
Robert L Findling, Ann C Childress, Andrew J Cutler, et al.
Journal of Child and Adolescent Psychopharmacology
|
March 4, 2020
Randomized, Double-Blind, Placebo-Controlled, Flexible-Dose Titration Study of Methylphenidate Hydrochloride Extended-Release Capsules (Aptensio XR) in Preschool Children with Attention-Deficit/Hyperactivity Disorder
Ann C Childress, Scott H Kollins, Henry C Foehl, et al.
Neuropsychiatric Disease and Treatment
|
June 11, 2021
The Effect of Viloxazine Extended-Release Capsules on Functional Impairments Associated with Attention-Deficit/Hyperactivity Disorder (ADHD) in Children and Adolescents in Four Phase 3 Placebo-Controlled Trials
Azmi Nasser, Joseph T Hull, Tesfaye Liranso, et al.
Journal of Child and Adolescent Psychopharmacology
|
December 7, 2017
Efficacy and Safety of Amphetamine Extended-Release Oral Suspension in Children with Attention-Deficit/Hyperactivity Disorder
Ann C Childress, Sharon B Wigal, Matthew N Brams, et al.
The Journal of Clinical Psychiatry
|
July 20, 2022
Randomized, Double-Blind, Placebo-Controlled, Fixed-Dose Study to Evaluate the Efficacy and Safety of Amphetamine Extended-Release Tablets in Adults With Attention-Deficit/Hyperactivity Disorder
Andrew J Cutler, Ann C Childress, Antonio Pardo, et al.
Npj Mental Health Research
|
August 22, 2025
Real-world effectiveness of a widely available digital health program in adults reporting a lifetime diagnosis of ADHD
Allen M Osman, Kevin P Madore, Paul I Jaffe, et al.
Journal of Child and Adolescent Psychopharmacology
|
April 30, 2024
From Consensus Statement to Pills to Pixels: New Innovations in Attention-Deficit/Hyperactivity Disorder Care
Raman Baweja, Stephen V Faraone, Ann C Childress, et al.
The Journal of Clinical Psychiatry
|
June 24, 2021
Symptomatic and Functional Response and Remission From the Open-Label Treatment-Optimization Phase of a Study With DR/ER-MPH in Children With ADHD
Ann C Childress, Andrew J Cutler, Michelle D Po, et al.
Page
of 9